Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection.
about
Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis BThe clinical implications of hepatitis B virus genotypes and HBeAg in pediatricsThe woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infectionImmune tolerance split between hepatitis B virus precore and core proteins.Protection against woodchuck hepatitis virus (WHV) infection by gene gun coimmunization with WHV core and interleukin-12.Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks.The woodchuck model of hepatitis B virus infection.Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation.Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection.Control or persistence of hepatitis B virus: the critical role of initial host-virus interactions.Genetic changes in hepatitis delta virus from acutely and chronically infected woodchucks.Superinfection with woodchuck hepatitis virus strain WHVNY of livers chronically infected with strain WHV7Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.Rapid production of neutralizing antibody leads to transient hepadnavirus infection.Capacity of a natural strain of woodchuck hepatitis virus, WHVNY, to induce acute infection in naive adult woodchucks.Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma.AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B.Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-cell responses to pre-S and S regions of the viral envelope protein.Experimental chronic hepatitis B infection of neonatal tree shrews (Tupaia belangeri chinensis): a model to study molecular causes for susceptibility and disease progression to chronic hepatitis in humans.Hepatitis B virus genetic variants: biological properties and clinical implicationsImmunomodulation as an option for the treatment of chronic hepatitis B virus infection: preclinical studies in the woodchuck model.Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, ChinaCorrelation of virus and host response markers with circulating immune complexes during acute and chronic woodchuck hepatitis virus infection.Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzymeSemliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma.Mechanisms of Hepatitis B Virus Persistence.Infection Patterns Induced in Naive Adult Woodchucks by Virions of Woodchuck Hepatitis Virus Collected during either the Acute or Chronic Phase of Infection.Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck.Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus.Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein.Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks.Quantification of hepatitis B virus genomes and infectivity in human serum samples.Expression of matrix metalloproteinases and their inhibitors in the woodchuck model of hepatocellular carcinoma.The woodchuck hepatitis B virus infection model for the evaluation of HBV therapies and vaccine therapies.Interferon-gamma-associated responses to woodchuck hepatitis virus infection in neonatal woodchucks and virus-infected hepatocytes.Animal models for the study of hepatitis B virus infection.
P2860
Q27318089-DC9BF9FA-647F-46D5-BA6A-6C4C363CF679Q28073299-4CFF85E5-BC42-4C61-9E17-C0EAACFC328CQ33787525-355EADB6-B98A-4E6B-AA6D-AEC3618F5A57Q33835018-2198F621-17A5-422A-A657-82C363942FA8Q33845287-D4B0DFA4-3252-48B4-8E46-A63C721E9295Q33883722-C98EF70C-C898-4728-B742-5823F3AEC885Q34077043-4D620DC3-ED95-4001-9F25-A94E986B9509Q34282796-A61B1BA6-1889-49C5-9F80-030B661C0C33Q34330734-0FE81681-CBFD-4CF0-B20E-BB296BDAA989Q34365631-FCBB3BAD-5C09-4421-8BB0-B52672981FB8Q34546460-DD305C68-B338-4504-8F8C-79D5C48705DFQ34716814-86D7A7BC-0A18-4799-A301-01AC7311FF6DQ34992624-E7D0EB71-24FF-4882-81BB-F21587D35C24Q35076712-3473E54A-81D3-4338-ACAB-978F1B166B0EQ35543965-798F96AE-39ED-4E12-BDAF-D132992493DAQ35751930-BED6756B-B83F-4E49-A434-CFAE31DF1C45Q35766015-4F58C624-556B-4D12-9DF1-A132608D6BE5Q35866293-93EEA363-9A17-462F-9DE7-82BBF6B5FF5EQ36094811-372A9D6F-41B4-466F-A7F6-BCE144FC93E3Q36099102-20516960-C24D-4FD2-B602-0B1590219EABQ36437146-957B9136-26D0-4254-9E2A-C2F6E9BDE020Q36795324-41082A10-97FD-448D-B340-BAB9D6A30678Q36821357-D8EBF889-C23D-48CF-AC67-E657B814F1C3Q36932959-12079A54-2F83-40E9-9B63-3AC54F6698FBQ36971122-677006B5-261B-4D97-A14C-AF6BDF978511Q37099867-63A164AC-65D0-4CC9-98B7-587B8FEAF139Q37145283-9A6DB7FD-1BCB-460D-9FB4-2E544889F0A1Q37452091-414247A0-3EF2-44B1-A1CB-51162AADA1CCQ40077350-3B9FCBBF-231E-4C96-BEA6-7965F542A2E2Q40847895-B8698273-EA27-4FD0-9C4F-8B6C51C529C2Q41218508-E9FA02A6-9E29-4CCE-8FBA-C11C4CB9BC8AQ42129273-FEFD9004-BD64-4B55-B1F8-7407A1794A01Q42272234-40B198BC-BC1C-4671-B25D-DB91F5DC9619Q42416375-5C216C64-37AB-4447-BE7E-F867D3D7138FQ44147084-67ACB488-4D8C-488C-9EEF-492374190C1DQ44394234-78FA3BB8-2639-41A9-A88C-B55FEB82B723Q45356038-BD648084-0173-4650-93A1-94F06E6720C7Q45591313-A062DBDB-ABD7-44EA-84E8-4CF6C8B21182Q52671153-D39F4AFC-1028-43F4-B309-8517F76C7BF2
P2860
Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Effects of age and viral deter ...... uck hepatitis virus infection.
@en
Effects of age and viral deter ...... uck hepatitis virus infection.
@nl
type
label
Effects of age and viral deter ...... uck hepatitis virus infection.
@en
Effects of age and viral deter ...... uck hepatitis virus infection.
@nl
prefLabel
Effects of age and viral deter ...... uck hepatitis virus infection.
@en
Effects of age and viral deter ...... uck hepatitis virus infection.
@nl
P2093
P2860
P356
P1433
P1476
Effects of age and viral deter ...... uck hepatitis virus infection.
@en
P2093
Baldwin BH
Hornbuckle WE
Purcell RH
Tennant BC
P2860
P304
P356
10.1002/HEP.510310128
P407
P577
2000-01-01T00:00:00Z